STAT3 and ovarian carcinoma: Because STAT3 is involved in the proliferation and poor overall survival of EOC23, and blocking STAT3 signalling has been shown to suppress ovarian cancer progression in an experimental animal model24, STAT3 is considered a target molecule for treating patients with advanced EOC.